[
    [
        {
            "time": "",
            "original_text": "透明质酸入食孕育200亿元蓝海市场，品牌入局进行时",
            "features": {
                "keywords": [
                    "透明质酸",
                    "蓝海市场",
                    "品牌入局"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "透明质酸入食孕育200亿元蓝海市场，品牌入局进行时",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "化妆品医美行业2021年中报前瞻：行业维持高景气 龙头公司享估值溢价",
            "features": {
                "keywords": [
                    "医美",
                    "高景气",
                    "龙头公司",
                    "估值溢价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美",
                    "化妆品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "化妆品医美行业2021年中报前瞻：行业维持高景气 龙头公司享估值溢价",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-07-20",
            "original_text": "7月20日华熙生物、中远海能等6家公司公告出现利空",
            "features": {
                "keywords": [
                    "华熙生物",
                    "中远海能",
                    "利空"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美",
                    "能源运输"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "7月20日华熙生物、中远海能等6家公司公告出现利空",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "黑色医美产业链等“你”上钩：黑针剂成本几十卖千元，黑医师从业超15万人",
            "features": {
                "keywords": [
                    "黑色医美",
                    "黑针剂",
                    "黑医师"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "黑色医美产业链等“你”上钩：黑针剂成本几十卖千元，黑医师从业超15万人",
                "Correlation": 5,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363.SH)：赢瑞物源完成集中竞价减持1%股份 减持股份",
            "features": {
                "keywords": [
                    "华熙生物",
                    "赢瑞物源",
                    "减持"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华熙生物(688363.SH)：赢瑞物源完成集中竞价减持1%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363.SH)股东赢瑞物源累计减持480万股 减持实施完毕 减持股份",
            "features": {
                "keywords": [
                    "华熙生物",
                    "赢瑞物源",
                    "减持"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华熙生物(688363.SH)股东赢瑞物源累计减持480万股 减持实施完毕 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物：股东赢瑞物源累计减持1%股份 减持股份",
            "features": {
                "keywords": [
                    "华熙生物",
                    "赢瑞物源",
                    "减持"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华熙生物：股东赢瑞物源累计减持1%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "山东区域股市周报：板块总市值涨468亿，华熙生物挤进板块市值3强",
            "features": {
                "keywords": [
                    "华熙生物",
                    "板块市值",
                    "上涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医美",
                    "区域经济"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "山东区域股市周报：板块总市值涨468亿，华熙生物挤进板块市值3强",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "商业贸易行业周观点：奥园美谷发力高端医美产品 中国钻石交易强劲反弹",
            "features": {
                "keywords": [
                    "奥园美谷",
                    "高端医美",
                    "钻石交易",
                    "反弹"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美",
                    "商业贸易"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "商业贸易行业周观点：奥园美谷发力高端医美产品 中国钻石交易强劲反弹",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)深度报告：四轮驱动战略建立透明质酸全产业链布局",
            "features": {
                "keywords": [
                    "华熙生物",
                    "四轮驱动",
                    "透明质酸",
                    "全产业链"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物(688363)深度报告：四轮驱动战略建立透明质酸全产业链布局",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国金证券维持华熙生物买入评级：四轮驱动战略建立透明质酸全产业链布局",
            "features": {
                "keywords": [
                    "华熙生物",
                    "国金证券",
                    "买入评级",
                    "四轮驱动",
                    "透明质酸"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国金证券维持华熙生物买入评级：四轮驱动战略建立透明质酸全产业链布局",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]